{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:38:37Z","timestamp":1777095517037,"version":"3.51.4"},"reference-count":32,"publisher":"University of Tokushima Faculty of Medicine","issue":"1.2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2152\/jmi.73.92","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:10:41Z","timestamp":1776895841000},"page":"92-100","source":"Crossref","is-referenced-by-count":0,"title":["Composition of Gut Microbiota and Its Relationship with Inflammatory Markers in Healthy Individuals and Patients with Ulcerative Colitis or Crohn\u2019s Disease"],"prefix":"10.2152","volume":"73","author":[{"given":"Hideo","family":"Watanabe","sequence":"first","affiliation":[{"name":"Watanabe Hospital, 7-13-3 Kuukou-touri, Matsuyama City, Ehime, 791-0054, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Ono","sequence":"additional","affiliation":[{"name":"Watanabe Hospital, 7-13-3 Kuukou-touri, Matsuyama City, Ehime, 791-0054, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Oshikiri","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Surgical Oncology, Ehime University Graduate School of Medicine, 454, Shitsukawa, Toon-shi, Ehime 791-0295, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology, Tokushima University Graduate School, 1-78-1 Sho-machi, Tokushima 770-8505, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Goldsmith JR, Sartor RB:The role of diet on intestinal microbiota metabolism:downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol 49:785-798, 2014","DOI":"10.1007\/s00535-014-0953-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sheehan D, Moran C, Shanahan F:The microbiota in inflammatory bowel disease. J Gastroenterol 50:495-507, 2015","DOI":"10.1007\/s00535-015-1064-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sartor RB:Intestinal microflora in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol 17:324-330, 2001","DOI":"10.1097\/00001574-200107000-00005"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, Inatomi O, Bamba S, Sugimoto M, Andoh A:Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn\u2019s Disease. Digestion 93:59-65, 2016","DOI":"10.1159\/000441768"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Seo K, Seo J, Yeun J, Choi H, Kim YI, Chang SY:The role of mucosal barriers in human gut health. Arch Pharm Res 44:325-341, 2021","DOI":"10.1007\/s12272-021-01327-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Dayani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G, Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahedi H, Sood A, Sung JY, Malekzadeh R, Westra HJ, Yamazaki K, Yang SK, International Multiple Sclerosis Genetics C, International IBD Genetics Consortium, Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK:Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47:979-986, 2015","DOI":"10.1038\/ng.3359"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Guo X, Huang C, Xu J, Xu H, Liu L, Zhao H, Wang J, Huang W, Peng W, Chen Y, Nie Y, Zhou Y, Zhou Y:Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease. Front Nutr 8:818902, 2022","DOI":"10.3389\/fnut.2021.818902"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Brown EL, Essigmann HT, Hoffman KL, Petrosino J, Jun G, Brown SA, Aguilar D, Hanis CL:C-Reactive Protein Levels Correlate with Measures of Dysglycemia and Gut Microbiome Profiles. Curr Microbiol 81:45, 2023","DOI":"10.1007\/s00284-023-03560-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kanda Y:Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452-458, 2013","DOI":"10.1038\/bmt.2012.244"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA:Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol 10:277, 2019","DOI":"10.3389\/fimmu.2019.00277"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lee WJ, Hase K:Gut microbiota-generated metabolites in animal health and disease. Nat Chem Biol 10:416-424, 2014","DOI":"10.1038\/nchembio.1535"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Obata Y, Furusawa Y, Hase K:Epigenetic modifications of the immune system in health and disease. Immunol Cell Biol 93:226-232, 2015","DOI":"10.1038\/icb.2014.114"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC:A Review of Inflammatory Bowel Disease:A Model of Microbial, Immune and Neuropsychological Integration. Public Health Rev 42:1603990, 2021","DOI":"10.3389\/phrs.2021.1603990"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M, Lochs H:Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54, 2002","DOI":"10.1053\/gast.2002.30294"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Amiri P, Hosseini SA, Ghaffari S, Tutunchi H, Ghaffari S, Mosharkesh E, Asghari S, Roshanravan N:Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases:A comprehensive narrative review. Front Pharmacol 12:837509, 2022","DOI":"10.3389\/fphar.2021.837509"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shin Y, Han S, Kwon J, Ju S, Choi TG, Kang I, Kim SS:Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease. Nutrients 15:4466, 2023","DOI":"10.3390\/nu15204466"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhao H, Zhou Y, Xu J, Zhang Y, Wang H, Zhao C, Huang H, Yang J, Huang C, Li Y, Wang L, Nie Y:Short-chain fatty acid-producing bacterial strains attenuate experimental ulcerative colitis by promoting M2 macrophage polarization via JAK\/STAT3\/FOXO3 axis inactivation. J Transl Med 22:369, 2024","DOI":"10.1186\/s12967-024-05122-w"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K:Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-341, 2011","DOI":"10.1126\/science.1198469"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhang Z, Zhang H, Chen T, Shi L, Wang D, Tang D:Regulatory role of short-chain fatty acids in inflammatory bowel disease. Cell Commun Signal 20:64, 2022","DOI":"10.1186\/s12964-022-00869-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Jiang Z, Wu C:Reciprocal Interactions Between Regulatory T Cells and Intestinal Epithelial Cells. Front Immunol 13:951339, 2022","DOI":"10.3389\/fimmu.2022.951339"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gasaly N, Hermoso MA, Gotteland M:Butyrate and the Fine-Tuning of Colonic Homeostasis:Implication for Inflammatory Bowel Diseases. Int J Mol Sci 22:3061, 2021","DOI":"10.3390\/ijms22063061"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H:Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446-450, 2013","DOI":"10.1038\/nature12721"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Recharla N, Geesala R, Shi XZ:Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease:A Literature Review. Nutrients 15:2275, 2023","DOI":"10.3390\/nu15102275"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Louis P, Flint HJ:Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294:1-8, 2009","DOI":"10.1111\/j.1574-6968.2009.01514.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ:Differences between tissue-associated intestinal microfloras of patients with Crohn\u2019s disease and ulcerative colitis. J Clin Microbiol 44:4136-4141, 2006","DOI":"10.1128\/JCM.01004-06"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Xu Y, Xie R, Weng Y, Fang Y, Chen H, Tao S, Zhang H, Ye Y, Deng X, Han A, Jiang Q, Liang W:Unveiling the diagnostic and pro-inflammatory role of crohn\u2019s disease:insights from 16 S-guided discovery and species-specific validation. BMC Gastroenterol 25:468, 2025","DOI":"10.1186\/s12876-025-04061-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nakajo K, Yamazaki M, Chung H, Xu Y, Qiu H:Trends in the prevalence and incidence of Crohn\u2019s disease in Japan and the United States. Int J Colorectal Dis 39:61, 2024","DOI":"10.1007\/s00384-024-04636-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kim P, Joe S, Kim H, Jeong H, Park S, Song J, Kim W, Lee YG:Hidden Partner of Immunity:Microbiome as an Innovative Companion in Immunotherapy. Int J Mol Sci 26:856, 2025","DOI":"10.3390\/ijms26020856"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Alexandrescu L, Nicoara AD, Tofolean DE, Herlo A, Nelson Twakor A, Tocia C, Trandafir A, Dumitru A, Dumitru E, Aftenie CF, Preotesoiu I, Dina E, Tofolean IT:Healing from Within:How Gut Microbiota Predicts IBD Treatment Success-A Systematic Review. Int J Mol Sci 25:8451, 2024","DOI":"10.3390\/ijms25158451"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Manes A, Di Renzo T, Dodani L, Reale A, Gautiero C, Di Lauro M, Nasti G, Manco F, Muscariello E, Guida B, Tarantino G, Cataldi M:Pharmacomicrobiomics of Classical Immunosuppressant Drugs:A Systematic Review. Biomedicines 11:2562, 2023","DOI":"10.3390\/biomedicines11092562"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Becker HEF, Demers K, Derijks LJJ, Jonkers DMAE, Penders J:Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease. Front Microbiol 14:1107976, 2023","DOI":"10.3389\/fmicb.2023.1107976"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lazarevi\u0107 S, \u0110anic M, Al-Salami H, Mooranian A, Mikov M:Gut Microbiota Metabolism of Azathioprine:A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease. Front Pharmacol 13:879170, 2022","DOI":"10.3389\/fphar.2022.879170"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/73\/1.2\/73_92\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:57:59Z","timestamp":1777093079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/73\/1.2\/73_92\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"journal-issue":{"issue":"1.2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.73.92","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}